Patients with CARD8 mutations and excessive IL-1β production leading to Crohn's disease are in principle similar to patients with IL-10 abnormalities since in both cases increased NLRP3 inflammasome hyperactivity is due to lack of an inflammasome inhibitor (see Figure 1). Here, NLRP3 is linked to Crohn disease.